417 related articles for article (PubMed ID: 18824610)
1. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
[TBL] [Abstract][Full Text] [Related]
2. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis.
Walker J; Gongora R; Vasquez JJ; Drummelsmith J; Burchmore R; Roy G; Ouellette M; Gomez MA; Saravia NG
Mol Biochem Parasitol; 2012 Jun; 183(2):166-76. PubMed ID: 22449941
[TBL] [Abstract][Full Text] [Related]
3. Characterization of natural antimony resistance in Leishmania donovani isolates.
Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
[TBL] [Abstract][Full Text] [Related]
4. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of antimony resistance in Leishmania.
Ashutosh ; Sundar S; Goyal N
J Med Microbiol; 2007 Feb; 56(Pt 2):143-53. PubMed ID: 17244793
[TBL] [Abstract][Full Text] [Related]
6. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
[No Abstract] [Full Text] [Related]
7. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
8. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.
Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA
Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396
[TBL] [Abstract][Full Text] [Related]
9. Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials.
Wyllie S; Vickers TJ; Fairlamb AH
Antimicrob Agents Chemother; 2008 Apr; 52(4):1359-65. PubMed ID: 18250189
[TBL] [Abstract][Full Text] [Related]
10. Leishmania spp.: proficiency of drug-resistant parasites.
Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
[TBL] [Abstract][Full Text] [Related]
11. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione.
Yan S; Li F; Ding K; Sun H
J Biol Inorg Chem; 2003 Jul; 8(6):689-97. PubMed ID: 12827457
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
Fernández OL; Diaz-Toro Y; Ovalle C; Valderrama L; Muvdi S; Rodríguez I; Gomez MA; Saravia NG
PLoS Negl Trop Dis; 2014 May; 8(5):e2871. PubMed ID: 24853871
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.
Mohebali M; Kazemirad E; Hajjaran H; Kazemirad E; Oshaghi MA; Raoofian R; Teimouri A
Arch Dermatol Res; 2019 Jan; 311(1):9-17. PubMed ID: 30390113
[TBL] [Abstract][Full Text] [Related]
14. Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.
Brochu C; Wang J; Roy G; Messier N; Wang XY; Saravia NG; Ouellette M
Antimicrob Agents Chemother; 2003 Oct; 47(10):3073-9. PubMed ID: 14506011
[TBL] [Abstract][Full Text] [Related]
15. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
[TBL] [Abstract][Full Text] [Related]
16. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
Berman JD; Lee LS
J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony.
Fonseca MS; Comini MA; Resende BV; Santi AM; Zoboli AP; Moreira DS; Murta SM
Exp Parasitol; 2017 Apr; 175():36-43. PubMed ID: 28167207
[TBL] [Abstract][Full Text] [Related]
18. Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.
Andrade JM; Baba EH; Machado-de-Avila RA; Chavez-Olortegui C; Demicheli CP; Frézard F; Monte-Neto RL; Murta SM
Antimicrob Agents Chemother; 2016 Aug; 60(8):4482-9. PubMed ID: 27161624
[TBL] [Abstract][Full Text] [Related]
19. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.
Mukhopadhyay R; Dey S; Xu N; Gage D; Lightbody J; Ouellette M; Rosen BP
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10383-7. PubMed ID: 8816809
[TBL] [Abstract][Full Text] [Related]
20. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
